|
|
40
|
|
|
A2334
|
|
|
APO-GABAPENTIN 400MG CAP (APO/COL)
|
|
|
GABAPENTIN
|
|
|
APO-GABAPENTIN
|
|
|
100'S
|
|
|
C
|
|
|
17.67
|
|
|
0.18
|
|
|
400MG
|
|
|
CAPSULE
|
|
|
0
|
|
|
CAP
|
|
|
APO
|
|
|
APOTEX INC.
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
Yes
|
|
|
281292
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|